Filters:
Organization: C2N Diagnostics3 Projects | 2 Researchers | $2,772,719 Invested
2020
C2N Diagnostics
Kevin Yarasheski, PhD
Clinical Validation and Accreditation for Plasma Aß42/Aß40 as a Biomarker for Alzheimer’s Disease Pathology
2010
C2N Diagnostics
Tim West, PhD
Preclinical development of plasma based AD diagnostic test using a combination of antibody administration and stable isotope labeling kinetics
2008
C2N Diagnostics
Tim West, PhD
Validation and Optimization of an Immunoprecipitation Assay for Amyloid Beta from Human Cerebrospinal Fluid Using Novel Antibodies